The Irish Competition Authority clears a merger subject to two behavioral remedies in the private technologically advanced hospitals market (Bon Secours / Barringtons)

Introduction 1. On 21 December 2016 the Competition and Consumer Protection Commission (CCPC), [1] Ireland’s competition agency, cleared, after an extended Phase I, the acquisition whereby Bon Secours Health System Company Limited by Guarantee (Bon Secours) would acquire sole control of Barringtons Hospital (Barringtons), subject to two behavioural remedies. [2] It was determined that given these remedies the merger would not lead to a substantial lessening of competition (SLC), the competition test used by the CCPC. The transaction was notified to the CCPC on 24 August 2016. There was no appeal on the CCPC’s decision. [3] Background 2. Bons Secours is a “not-for-profit organisation founded in in 1824 by the Sisters of Bon Secours. … the group is the largest independent hospital group in

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Trinity College Dublin

Quotation

Paul Gorecki, The Irish Competition Authority clears a merger subject to two behavioral remedies in the private technologically advanced hospitals market (Bon Secours / Barringtons), 21 December 2016, e-Competitions December 2016, Art. N° 93690

Visites 63

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues